FSL0622
- Structure
- InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)
- InChIKey=CGIGDMFJXJATDK-UHFFFAOYSA-N
- Synonyms
-
- Origin
- Chemically synthesized
- Biological activities
- Inhibition of the COX-dependent formation of prostaglandin precursors
- Therapeutic
-
Antiinflammatory
Antipyretic
- Target
-
COX-1
COX-2
Phospholipase A2 (PLA2)
- Assay information
-
Inhibitor of phospholipase A2 (IC50 = 145 mM)
Inhibitor of the enzymatic activities of COX-1 (IC50 = 0.01 μg/ml) and COX-2 (IC50 = 0.6 μg/ml)
Inhibitor of the enzymatic activities of hCOX-1 (IC50 = 0.08 mM) and hCOX-2 (IC50 = 0.96 mM)
Inhibitor of the production of prostaglandins
Inducer of differentiation of C3H10T1/2 cells to adipocytes through binding to PPARγ (EC50 = approximately 80 μM)
- References
-
-
Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, Kliewer SA
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.
J Biol Chem, 272(6): 3406-3410 (1997) 9013583
-
Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Nature, 384(6610): 644-648 (1996) 8967954 doi: 10.1038/384644a0
-
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR
Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.
Proc Natl Acad Sci U S A, 90(24): 11693-11697 (1993) 8265610
-
Kaplan L, Weiss J, Elsbach P
Low concentrations of indomethacin inhibit phospholipase A2 of rabbit polymorphonuclear leukocytes.
Proc Natl Acad Sci U S A, 75(6): 2955-2958 (1978) 275865
-
Prostaglandins: Chemical and Biochemical Aspect
-
J. Am. Chem. Soc., 85: 488-489 (1963)